This inventor holds 38 USPTO granted patents and 1 published patent application, plus 9 CIPO patents and 23 EPO patents, primarily in Indazole Compounds. Top assignee: Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a.. Active years: 2009-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Roma, IT (2009)
- Rome, IT (2010 - 2022)
Company Filing History:
Years Active: 2009-2025
Areas of Expertise:
Title: Guido Furlotti: A Visionary Innovator in Pharmaceutical Chemistry
Introduction: Guido Furlotti, based in Rome, Italy, is a prolific inventor known for his impressive portfolio of 38 patents. Furlotti has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel processes and compounds that address various health conditions.
Latest Patents: Among Furlotti's latest innovations is a patent for a continuous process for the preparation of trazodone. This improved method involves a continuous process performed in a flow reactor, enhancing the efficiency of trazodone synthesis. Another notable patent registered by Furlotti focuses on 1H-indazole-3-carboxamide compounds, recognized for their role as glycogen synthase kinase 3 beta (GSK-3β) inhibitors. These compounds have implications for treating a range of disorders including insulin-resistance, neurodegenerative diseases, mood disorders, and various inflammatory conditions.
Career Highlights: Furlotti's career spans various roles in influential companies, notably at Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a., where he honed his skills and contributed to groundbreaking pharmaceutical innovations. His work consistently pushes the boundaries of what's possible in the field, leading to advancements that have the potential to transform patient care.
Collaborations: Throughout his career, Furlotti has collaborated with esteemed professionals in his field, including Nicola Cazzolla and Maria Alessandra Alisi. These partnerships reflect the collaborative nature of innovation in the pharmaceutical industry, where diverse expertise comes together to foster advancements.
Conclusion: Guido Furlotti exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions through numerous patents, particularly in the development of new processes and compounds for medical use, underline his commitment to advancing healthcare solutions. As he continues to explore new avenues in his research, Furlotti stands as a prominent figure among inventors striving to improve the quality of life through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile